Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02697357 · ClinicalTrials.gov registry record

Emotion Regulation Therapy to Address Distress Among Caregivers

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
32
Enrollment target

NCT02697357: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT02697357 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02697357 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
32 participants
Enrollment target

Study Summary

The aim of this study is to adapt and pilot test a type of therapy called Emotion Regulation Therapy (ERT-C) for informal caregivers of patients with cancer. Informal caregivers include partners, family members, children, parents, and friends providing informal care to a patient. Providing care to someone with cancer can be difficult. The purpose of this intervention is to improve coping and physical well-being among caregivers, which in turn will allow them to provide better care for their loved ones. Investigators would also like to learn about biological factors like stress that may affect one's emotional and physical well-being. This study will allow to better understand caregivers needs, and further develop a program to provide services to caregivers within MSKCC community and nationwide.

Primary Outcome

feedback from participants by qualitative research methods

Interventions

  • BEHAVIORAL Psychosocial Instruments
  • BEHAVIORAL Emotion Regulation Therapy for Cancer Caregivers (ERT-C)

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2015-10
Est. Completion 2020-07-09
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT02697357 record still lists

NCT02697357 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Psychosocial Instruments is the first listed.

NCT02697357 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02697357 about?

NCT02697357 is a clinical study titled "Emotion Regulation Therapy to Address Distress Among Caregivers". The aim of this study is to adapt and pilot test a type of therapy called Emotion Regulation Therapy (ERT-C) for informal caregivers of patients with cancer. Informal caregivers include partners, family members, children, parents, and friends providing informal care to a patient. Providing care to s...

What is the current status of trial NCT02697357?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2015-10. Estimated completion is 2020-07-09.

What interventions are being tested in trial NCT02697357?

The interventions under investigation include: Psychosocial Instruments (BEHAVIORAL), Emotion Regulation Therapy for Cancer Caregivers (ERT-C) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02697357?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02697357, the US trial registry maintained by the National Library of Medicine. NCT02697357 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.